Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues and adjusted earnings for the second quarter of fiscal 2026.
MDT Earnings: Medtronic Q2 FY26 revenue and adj. profit beat estimates
Categories
Healthcare Technology
Earnings Summary: Highlights of IDEXX’s Q3 2025 report
Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and earnings for the third quarter of fiscal 2025.
Earnings Summary: A snapshot of Revvity’s (RVTY) Q3 2025 report
Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, reported a decline in adjusted earnings for the third quarter
Earnings Summary: Highlights of Boston Scientific’s Q3 2025 results
Medical device maker Boston Scientific Corporation (NYSE: BSX) on Wednesday reported financial results for the third quarter of 2025. The company also issued
Intuitive Surgical (ISRG) Q3 FY25 revenue and earnings beat estimates
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) on Wednesday reported stronger-than-expected revenue and earnings for the third quarter of fiscal 2025.
Innovation pipeline, portfolio in focus ahead of Johnson & Johnson’s Q3 earnings
For Johnson & Johnson (NYSE: JNJ), 2025 has been a strong year, marked by an impressive financial performance that drove the stock
Earnings Summary: AngioDynamics (ANGO) reports Q1 loss; sales up 12.2%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Thursday reported a net loss for the first quarter of 2026. Revenues increased 12.2%
McKesson Corporation (MCK) raises FY26 earnings guidance
McKesson Corporation (NYSE: MCK), a diversified healthcare service company that operates in partnership with biopharma companies and care providers, has published its
Earnings Summary: A snapshot of CooperCompanies’ (COO) Q3 2025 report
Medical device maker CooperCompanies (NYSE: COO) has reported a double-digit increase in adjusted earnings for the third quarter of 2025 amid strong
IPO News: Picard Medical files for US IPO amid growth push
After a modest start to the year, IPO activity gained momentum in the second quarter, despite lingering macro headwinds and policy uncertainty.
MDT Earnings: Medtronic Q1 2026 adj. profit rises on higher sales
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported an increase in net sales and adjusted earnings for the first quarter
Strategic partnerships have been essential to Profusa’s progress: CEO Ben Hwang
Profusa, Inc. (NASDAQ: PFSA) is a digital health company pioneering a new generation of biointegrated sensors. Its injectable biosensors are designed to
Earnings Summary: Revvity (RVTY) reports higher Q2 2025 revenues
Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenues for the second
Earnings Summary: CooperCompanies (COO) reports higher Q2 revenue and profit
Medical device maker CooperCompanies (NYSE: COO) has reported an increase in adjusted earnings for the second quarter of 2025, aided by a
Hinge Health is all set to go public. What investors need to know
The IPO market has witnessed steady activity so far this year, despite fluctuations in momentum across months. The technology industry continues to
MDT Earnings: A snapshot of Medtronic’s Q4 2025 report
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues for the fourth quarter of 2025, which translated into a
Earnings: Highlights of Thermo Fisher Scientific’s (TMO) Q1 2025 report
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced financial results for the first quarter of 2025, reporting a modest increase in
Earnings Summary: Highlights of CooperCompanies (COO) Q1 2025 results
Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the first quarter of 2025, reporting an increase in revenues and
Earnings Summary: DexCom reports preliminary Q4 2024 results
DexCom, Inc. (NASDAQ: DXCM) has announced preliminary financial results for the fourth quarter of 2024, reporting an 8% increase in revenues. The
Medtronic (MDT) reports higher revenue and profit for Q1 2025
Medical device maker Medtronic plc (NYSE: MDT) reported an increase in revenues and adjusted profit for the first quarter of 2025. First-quarter
Envoy Medical is well-positioned to gain market share in hearing implant space: CEO
Envoy Medical (NASDAQ: COCH) is a leader in hearing solutions, offering innovative hearing technologies and advanced hearing implants. Its fully implanted hearing